Ad is loading...
BSMKX
Price
$17.46
Change
-$0.21 (-1.19%)
Updated
Nov 15 closing price
VSCIX
Price
$118.04
Change
-$1.28 (-1.07%)
Updated
Nov 15 closing price
Ad is loading...

BSMKX vs VSCIX

Header iconBSMKX vs VSCIX Comparison
Open Charts BSMKX vs VSCIXBanner chart's image
iShares Russell Small/Mid-Cap Idx K
Price$17.46
Change-$0.21 (-1.19%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$118.04
Change-$1.28 (-1.07%)
VolumeN/A
CapitalizationN/A
BSMKX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BSMKX vs. VSCIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSMKX is a Buy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. BSMKX (650M). VSCIX pays higher dividends than BSMKX: VSCIX (1.43) vs BSMKX (1.32). BSMKX was incepted earlier than VSCIX: BSMKX (9 years) vs VSCIX (27 years). BSMKX is a more actively managed with annual turnover of: 30.00 vs. VSCIX (12.00). BSMKX (5000000) and VSCIX (5000000) have matching initial minimum investment requirements. VSCIX (30.27) and BSMKX (29.90) have marching annual gain over last year. VSCIX return over 5 years is better than : 55.65 vs. BSMKX (44.44).
BSMKXVSCIXBSMKX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD14.85515.79594%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets650M151B0%
Annual Yield % from dividends1.321.4392%
Returns for 1 year29.9030.2799%
Returns for 3 years-1.934.74-41%
Returns for 5 years44.4455.6580%
Returns for 10 yearsN/A123.35-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRRM23.420.10
+0.43%
Verra Mobility Corp
PRM12.160.04
+0.33%
Perimeter Solutions SA
TSCO275.66-1.42
-0.51%
Tractor Supply Company
ABEO5.86-0.09
-1.51%
Abeona Therapeutics
LPCN4.89-0.32
-6.14%
Lipocine